Centessa Pharmaceuticals plc ADR [CNTA] stock prices are down -0.17% to $23.34 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The CNTA shares have gain 9.42% over the last week, with a monthly amount glided 37.21%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Centessa Pharmaceuticals plc ADR [NASDAQ: CNTA] stock has seen the most recent analyst activity on September 03, 2025, when Wells Fargo initiated its Overweight rating and assigned the stock a price target of $31. On July 21, 2025, Truist initiated with a Buy rating and assigned a price target of $30 on the stock. Needham started tracking the stock assigning a Buy rating and suggested a price target of $35 on May 28, 2025. Chardan Capital Markets initiated its recommendation with a Buy and recommended $30 as its price target on May 08, 2025. Piper Sandler started tracking with a Overweight rating for this stock on March 31, 2025, and assigned it a price target of $38. In a note dated January 07, 2025, TD Cowen initiated a Buy rating.
The stock price of Centessa Pharmaceuticals plc ADR [CNTA] has been fluctuating between $9.60 and $23.51 over the past year. Currently, Wall Street analysts expect the stock to reach $22.33 within the next 12 months. Centessa Pharmaceuticals plc ADR [NASDAQ: CNTA] shares were valued at $23.34 at the most recent close of the market. An investor can expect a potential drop of -4.33% based on the average CNTA price forecast.
Analyzing the CNTA fundamentals
Gross Profit Margin for this corporation currently stands at 0.94% with Operating Profit Margin at -12.94%, Pretax Profit Margin comes in at -14.2%, and Net Profit Margin reading is -14.44%. To continue investigating profitability, this company’s Return on Assets is posted at -0.47, Equity is -0.56 and Total Capital is -0.45. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.34.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 22.99 points at the first support level, and at 22.63 for the second support level. However, for the 1st resistance point, the stock is sitting at 23.65, and for the 2nd resistance point, it is at 23.95.
Ratios To Look Out For
It’s worth pointing out that Centessa Pharmaceuticals plc ADR [NASDAQ:CNTA]’s Current Ratio is 10.12. In addition, the Quick Ratio stands at 10.12 and the Cash Ratio stands at 1.49. Considering the valuation of this stock, the price to sales ratio is 207.53, the price to book ratio is 9.06.
Transactions by insiders
Recent insider trading involved Accardi Mario Alberto, President, Orexin Program, that happened on Sep 16 ’25 when 8172.0 shares were sold. Officer, Accardi Mario Alberto completed a deal on Sep 16 ’25 to buy 8172.0 shares. Meanwhile, General Counsel HUSSAIN IQBAL J sold 6000.0 shares on Sep 15 ’25.
